Clinical Research Trial Enrollment
Psilocybin for Depression
This study is investigating the effects of Psilocybin, the psychoactive compound in “magic mushrooms”, on Major Depressive Disorder (MDD). The sponsor of the study is Usona Institute. This study is conducted under strict study-related medical supervision and participation is completely legal.
The first step to participating in this study is to complete a short pre-eligibility survey. Our team will review your responses and contact you with the next steps.
If you know someone struggling with depression who may be interested in this opportunity, please share this with them.
Principal Investigator
Professor Emeritus, UCSD | Founder, Kadima Neuropsychiatry
This study is done at Kadima Neuropsychiatry Institute in La Jolla, CA
Clinical Trial Summary: A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults with Major Depressive Disorder (MDD).
Read more about this study on ClinicalTrials.Gov